ArticleLeukemia research reports2021

MRD negative CR after azacitidine and venetoclax in a young patient with AML, unfit for intensive induction followed by ASCT.

Deepak Kumar Shukla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.